業績

  • 2012年

    ｜　Ａ．原著・症例報告

    Ａ．原著・症例報告

    • Sekine S, Kanamaru Y, Koike M, Nishihara A, Okada M, Kinoshita H, Kamiyama J, Maruyama J, Uchiyama Y, Ishihara N, Takeda K, Ichijo H.Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5. J Biol Chem.2012 Oct 5;287(41)3435-45.
    • Imaizumi Y, Okada Y, Akamatsu W, Koike M, Kuzumaki N, Hayakawa H, Nihira T, Kobayashi T,Ohyama M, Sato S, Takanashi M, Funayama M, Hirayama A, Soga T, Hishiki T, Suematsu M, Yagi T, Ito D, Kosakai A, Hayashi K, Shouji M, Nakanishi A, Suzuki N, Mizushima N, Amagai M, Uchiyama Y, Mochizuki H, Hattori N, Okano H. Mitochondrial dysfunction associated with increased oxidative stress and a-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain,2012 Oct6;5(1):35.
    • Klionsky D et al. Guidelines for the use and interpretation of assys for monitoring autophagy. Atuophagy .Autophagy.2012 Apr;8(4):445-544.
    • Kambe T, Shimura H, Ueno Y, Nishioka K, Tanaka R, Hattori N, Urabe T. Vivid Visual Hallucinations Manifested as the Initial Symptom in a Patient with Neurosyphilis. Psychosomatics. 2012 Sep 27. pii: S0033-3182(12)00122-3.
    • Ando M, Funayama M, Li Y, Kashihara K, Murakami Y, Ishizu N, Toyoda C, Noguchi K, Hashimoto T, Nakano N, Sasaki R, Kokubo Y, Kuzuhara S, Ogaki K, Yamashita C, Yoshino H, Hatano T, Tomiyama H, Hattori N. VPS35 mutation in Japanese patients with typical Parkinson’s disease. Mov Disord. 2012 Sep 15;27(11):1413-7.
    • Tomizawa Y, Yokoyama K, Hattori N. [Internal medicine and neurological diseases: progress in diagnosis and treatment topics: X. Neurological disorders in connective tissue disease]. Nihon Naika Gakkai Zasshi. 2012 Aug 10;101(8):2242-8.
    • Tomizawa Y, Yokoyama K, Saiki S, Takahashi T, Matsuoka J, Hattori N. Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability. J Int Med Res. 2012;40(4):1483-91.
    • Tanaka Y, Ueno Y, Miyamoto N, Shimada Y, Tanaka R, Hattori N, Urabe T. Patent foramen ovale and atrial septal aneurysm can cause ischemic stroke in patients with antiphospholipid syndrome. J Neurol. 2012 Jul 27.[ Epub ahead of print.]
    • Ogaki K, Li Y, Takanashi M, Ishikawa KI, Kobayashi T, Nonaka T, Hasegawa M, Kishi M, Yoshino H, Funayama M, Tsukamoto T, Shioya K, Yokochi M, Imai H, Sasaki R, Kokubo Y, Kuzuhara S, Motoi Y, Tomiyama H, Hattori N. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. Parkinsonism Relat Disord. 2012 Jul 18. [Epub ahead of print.]
    • Ogaki K, Li Y, Atsuta N, Tomiyama H, Funayama M, Watanabe H, Nakamura R, Yoshino H, Yato S, Tamura A, Naito Y, Taniguchi A, Fujita K, Izumi Y, Kaji R, Hattori N, Sobue G. Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS). Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2012 Oct;33(10):2527.e11-6.
    • Fusegi K, Hattori N, Mizuno Y, Mori H. The Unrelated Communication Interlude (UCI) – An automatic behavior phenomenon in Parkinson’s disease. Parkinsonism Relat Disord. 2012 Sep;18(8):986-9.
    • Funabe S, Takao M, Saito Y, Hatsuta H, Sugiyama M, Ito S, Kanemaru K, Sawabe M, Arai T, Mochizuki H, Hattori N, Murayama S. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa. Neuropathology. 2012 Jun 4. doi: 10.1111/j.1440-1789.2012.01329.x. [Epub ahead of print]
    • Shimura H, Mizuno Y, Hattori N. Parkin and Parkinson disease. Clin Chem. 2012 Aug;58(8):1260-1.
    • Ujiie S, Hatano T, Kubo S, Imai S, Sato S, Uchihara T, Yagishita S, Hasegawa K, Kowa H, Sakai F, Hattori N. LRRK2 I2020T mutation is associated with tau pathology. Parkinsonism Relat Disord. 2012 Aug;18(7):819-23.
    • Fukae J, Kawanabe T, Akao N, Kado M, Tokoro M, Yokoyama K, Hattori N. Longitudinal myelitis caused by visceral larva migrans associated with Toxocara cati infection: case report. Clin Neurol Neurosurg. 2012 Sep;114(7):1091-4.
    • Takanashi M, Hattori N. [Neurodegenerative diseases]. Nihon Rinsho. 2012 Jan;70(1):94-8. Review. Japanese.
    • Hattori N, Hasegawa K, Sakamoto T. Pharmacokinetics and effect of food after oral administration of prolonged-release tablets of ropinirole hydrochloride in Japanese patients with Parkinson’s disease. J Clin Pharm Ther. 2012 Oct;37(5):571-7.
    • Ogaki K, Hirayama T, Chijiiwa K, Fukae J, Furuya T, Noda K, Fujishima K, Hattori N, Takahashi T, Okuma Y. Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis. Neurologist. 2012 Mar;18(2):76-9.
    • Shimada K, Motoi Y, Ishiguro K, Kambe T, Matsumoto SE, Itaya M, Kunichika M, Mori H, Shinohara A, Chiba M, Mizuno Y, Ueno T, Hattori N. Long-term oral lithium treatment attenuates motor disturbance in tauopathy model mice: implications of autophagy promotion. Neurobiol Dis. 2012 Apr;46(1):101-8.
    • Shimada Y, Yoritaka A, Tanaka Y, Miyamoto N, Ueno Y, Hattori N, Takao U. Cerebral Infarction in a Young Man Using High-dose Anabolic Steroids. J Stroke Cerebrovasc Dis. 2012 Nov;21(8)906.e9-906.e11. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.013.
    • Hattori N. Autosomal dominant parkinsonism: its etiologies and differential diagnoses. Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S1-3.
    • Saiki S, Sato S, Hattori N. Molecular pathogenesis of Parkinson’s disease: update. J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):430-6.
    • Shimura H, Tanaka R, Urabe T, Tanaka S, Hattori N. Art and Parkinson’s disease: a dramatic change in an artist’s style as an initial symptom. J Neurol. 2012 May;259(5):879-81. Epub 2011 Oct 19.
    • Yamashiro K, Furuya T, Noda K, Urabe T, Hattori N, Okuma Y. Cerebral infarction developing in a patient without cancer with a markedly elevated level of mucinous tumor marker. J Stroke Cerebrovasc Dis. 2012 Oct;21(7):619.e1-2.
    • Yamashiro K, Mori A, Shimada Y, Furuya T, Noda K, Urabe T, Hattori N, Okuma Y. Gradient Echo T2*-weighted Magnetic Resonance Imaging Revealing Cerebral Microbleeds in A Patient with Microscopic Polyangiitis Complicated by Cerebrovascular Disease. J Stroke Cerebrovasc Dis. 2012 Nov;21(8):904.e7-9.
    • Yamashiro K, Tanaka R, Nishioka K, Ueno Y, Shimura H, Okuma Y, Hattori N, Urabe T. Cerebral Infarcts Associated with Adenomyosis Among Middle-aged Women. J Stroke Cerebrovasc Dis. 2012 Nov;21(8):910.e1-5.
    • Miyamoto N, Tanaka Y, Ueno Y, Tanaka R, Hattori N, Urabe T. Benefits of prestroke use of angiotensin type 1 receptor blockers on ischemic stroke severity. J Stroke Cerebrovasc Dis. 2012 Jul;21(5):363-8.
    • Tanaka R, Kawanabe T, Yamauchi Y, Shimura H, Tanaka Y, Miyamoto N, Ueno Y, Urabe T, Hattori N, Tanaka S. Economy class stroke syndrome after a long drive. J Stroke Cerebrovasc Dis. 2012 Feb;21(2):155-7.
    • Tanaka R, Shimada Y, Shimura H, Oizumi H, Hattori N, Tanaka S. Predominant vasogenic edema in a patient with fatal cerebral air embolism. J Stroke Cerebrovasc Dis. 2012 Aug;21(6):509-11.
    • Ichikawa-Tomikawa N, Ogawa J, Douet V, Xu Z, Kamikubo Y, Sakurai,T,Kohsaka S, Chiba H, Hattori H, Yamada Y, and Arikawa-Hirasawa E.　Laminin a1 is essential for mouse cerebellar development. Matrix Biol 2012 January;31(1):17-28.
    • Funayama M, Yoshino H, Li Y, Kusaka H, Tomiyama H, Hattori N. Pseudo-heterozygous rearrangement mutation of parkin. Mov Disord 2012 Apr;27(4)552-5.